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OBJECTIVES: To develop a new instrument applicable
to quality of life (QoL) assessment in patients suffering
from coronary artery disease and to evaluate reliability of
the results obtained with the use of this instrument in 
the Polish setting. METHODS: Construction of the 
POL-CAD questionnaire is based on a literature review
concerning different quality of life measures, experts’
opinions in cardiology ﬁeld, and interviews with patients.
POL-CAD includes 17 items clustered into 5 domains:
coronary pains, physical functioning, emotional status,
social activity and satisfaction with treatment. The score
for each domain is the sum of the items with the 0–20
range. The summary measure consists of the total score
for all domains. The validation study in Poland involved
57 patients with different Canadian Cardiovascular
Society (CCS) classiﬁcation and consisted of pre-testing
and two repeated QoL measures at a 4-week interval.
Visual analogue scale was also included, to measure indi-
viduals’ preferences and evaluate utility values for differ-
ent CAD states. RESULTS: Most of the patients (84.2%)
reported complete understanding of the questions and
73.7% were able to complete POL-CAD unaided. The
mean values of the total QoL score achieved were: 70.6
± 12.7 in CCS I, 57.7 ± 9.5 in CCS II and 50.1 ± 12.2 in
CCS III. Observed differences were statistically signiﬁcant
(p < 0.05). Results obtained for the stable patients were
fully repeatable at four weeks intervals. The differences
for the patients who changed the CCS over time were also
statistically signiﬁcant (p < 0.05). A very high correlation
0.9 > r > 0.7 of the coronary pain score with the total
score and also the high correlation 0.7 > r > 0.5 with the
scores for the remaining domains were observed. CON-
CLUSIONS: Quality of life assessment made with the use
of the POL-CAD correlates strongly with the states of
CAD according to CCS classiﬁcation. POL-CAD allows
provision of reliable assessment of the health related
quality of life in CAD patients.
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OBJECTIVE: The early results of a prospective one year
follow up study of HRQL of patients (pts) admitted to
32 general hospitals during a 10-month period for CHF
are reported. METHODS: Diagnosis was established
based on the European Society of Cardiology criteria 
and HRQL was measured with the SF-36 health proﬁle.
RESULTS: Of the 849 already recruited pts, information
of HRQL is available for 605pts at baseline and for 506
at one month. Forty-two percent were women, mean age
was 70 (from 17 to 96), 62% had previous diagnosis of
heart failure, 42% had diabetes mellitus, 40% had at least
one important comorbid condition, 49% had biventricu-
lar heart failure at admission and 37% had functional
class IV (New York Heart Association classiﬁcation).
Heart failure pts had low scores in all dimensions of the
SF-36 and improvement after admission was only modest.
At one month evaluation the Physical Component
Summary (PCS) score of the SF-36 increased from 33 to
35, and its determinants were PCS at baseline (beta coef-
ﬁcient of 5 for an increase of 10 units) and biventricular
heart failure (beta coefﬁcient of -3.37). The Mental Com-
ponent Summary (MCS) increased from 41 to 44 and its
determinants were PCS (beta coef. of 1.7 for a 10 units
increase) and MCS (beta coef. 4.2 for a 10 units increase)
at baseline, gender (beta coef. of -3.4 for women) and
comorbidity (beta coef. of -2.47). Eight percent of
patients died during the ﬁrst month, being PCS at base-
line (odds ratio of 0.96 for one unit increase) and age
(odds ratio of 1.09 for each year) independent predictors
of this short-term mortality. CONCLUSION: Compared
with pts with coronary syndromes these patients had
worse scores of general health perceptions and mental
health and also less improvement.
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OBJECTIVES: To investigate the effect of insulin glargine
(glargine) versus NPH insulin (NPH) on long-term out-
comes in Type 2 diabetes using the Diabetes Mellitus
Model (DMM). METHODS: The DMM predicts numer-
ous short- and long-term complications over 10 years,
based on published studies. The main inﬂuence on out-
comes is HbA1c, which is simulated over time. The version
